General Information
Revision date
2024-06-12
Product name
Voriconazole for Injection 200 mg/vial
1.2.1 Relevant identified uses
Pharmaceutical product used as antifungal agent
Manufacturer Name
Aspiro Pharma Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Hazardous Not listed
Hazard statements
Harmful if swallowed.
Additional information
Short Term May produce slight eye irritation, Active ingredient is not a skin irritant , Accidental ingestion may cause effects similar to those seen in clinical use. Long Term Adverse reproductive effects seen in repeat-dose animal studies are consistent with the pharmacologic action of this drug and are expected to be relevant to humans. Animal studies indicate that this material may cause adverse effects on the liver, the developing fetus. EU Risk Phrases R40 - Limited evidence of a carcinogenic effect. R43 - May cause sensitization by skin contact. R61 - May cause harm to the unborn child. This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
